From Seekingalpha · SA Transcripts · · 30s
Lexeo Therapeutics Discusses PKP2 Arrhythmogenic Cardiomyopathy
Lexeo Therapeutics presents clinical assessment for PKP2 arrhythmogenic cardiomyopathy unmet need.
In brief
Lexeo Therapeutics presents clinical assessment for PKP2 arrhythmogenic cardiomyopathy unmet need. Lexeo Therapeutics discusses clinical assessment and unmet need in PKP2 arrhythmogenic cardiomyopathy. Originally reported by Seekingalpha.
Lexeo Therapeutics
Lexeo Therapeutics published a slide deck discussing clinical assessment and unmet need in PKP2 arrhythmogenic cardiomyopathy.
Clinical Assessment
The company highlights clinical assessment for PKP2 arrhythmogenic cardiomyopathy unmet need.
Unmet Need
Lexeo Therapeutics discusses unmet need in PKP2 arrhythmogenic cardiomyopathy.
The takeaway
Lexeo Therapeutics discusses clinical assessment and unmet need in PKP2 arrhythmogenic cardiomyopathy.
